Table 1.
Time (wk) past initial treatment | |||||||||
0 | 4 | 8 | 16 | ||||||
FP | PCR | FP | PCR | FP | PCR | FP | PCR | ||
Juvenile mice | Treated (6 cages) | 6 | 6 | 6 | 2 | 0 | 2 | 0 | 0 |
Positive controls (2 cages) | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | |
Negative controls (8 cages) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Adult mice | Treated (6 cages) | 5 | 6 | 0 | 2 | 0 | 2 | 0 | 0 |
Positive controls (2 cages) | 1 | 2 | 0 | 2 | 2 | 2 | 2 | 2 | |
Negative controls (6 cages) | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
Juvenile mice were 5 wk old at the start of the study; adult mice were 28 wk old. Selamectin was administered to treated cages at 0 (initial treatment) and 4 wk.